• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/55 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds

Patent holdings for IPC class A61K 47/55

Total number of patents in this class: 1666

10-year publication summary

43
77
140
156
163
190
272
253
266
6
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Dana-Farber Cancer Institute, Inc.
2531
44
Purdue Research Foundation
3472
40
Yale University
2290
35
Sapreme Technologies B.V.
81
32
The Regents of the University of California
19479
28
Arvinas Operations, Inc.
208
20
Kymera Therapeutics, Inc.
199
18
Zevra Therapeutics, Inc.
89
15
University of Southern California
2076
14
Uppthera Inc.
16
12
Elysium Therapeutics, Inc.
18
11
Wisconsin Alumni Research Foundation
3819
10
Charite - Universitatsmedizin Berlin
384
10
Endocyte, Inc.
111
10
Extend Biosciences, Inc.
22
10
Icahn School of Medicine at Mount Sinai
895
9
Imbria Pharmaceuticals, Inc.
62
9
Diverse Biotech, Inc.
16
9
The Board of Trustees of the Leland Stanford Junior University
6226
8
Northwestern University
3271
8
Other owners 1314